Julie Holder

Dr Julie Holder is currently the Head of iPSC Innovation at Roslin Cells and is Head of facility at Cambridge, UK. Julie joined Roslin Cells after 26 years of working in the Pharmaceutical Industry and brings a knowledge of target validation, screening, primary assay development and in vivo experimental work with small molecules and Biopharmaceuticals. During her time in the Pharmaceutical Industry Julie has worked in both Drug Discovery and Preclinical Toxicology Departments and has been privileged to work on compounds at all stages of development in disease areas such as Diabetes, Respiratory, Neuroscience and Inflammation.